Inside the CAR-T Lupus Trial Halts: Safety, Science, and the Path Forward
Photo: www.lupusencyclopedia.com CAR-T cell therapy has been hailed as one of the most promising frontiers in autoimmune disease treatment, offering hope for long-term remission in patients with severe, treatment-resistant lupus. Sadly, the field hit a major speed bump after pharmaceutical leaders Novartis and Bristol